Etonitazene

This classification denotes an analgesic agent with the molecular formula C22H28N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9U3GT3353T, chemically known as 1h-benzimidazole-1-ethanamine, 2-((4-ethoxyphenyl)methyl)-n,n-diethyl-5-nitro- (9ci) but generally known as etonitazene, which bears US NIH Compound Identifier 13493. European Medicines Agency schedules Etonitazene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07334MIG. The term ETONITAZENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). ETONITAZENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etonitazene under HS 29339990 and SITC 51577. As of Q4 2014, ETONITAZENE remains the US FDA Preferred Term for this commodity. Etonitazene bears US NLM identifiers UMLS ID C0015132 and NCI Concept Code C65596. SMILES: O(C1CCC(CC2N(CCN(CC)CC)C3C(N2)CC([N](=O)O)CC3)CC1)CC.